Articles

Crowdfunding to cure Black Bone Disease

26th March 2015

Crowdfunding to cure Black Bone DiseaseSorsha Roberts

Black Bone Disease was the first genetic disease ever discovered over 100 years ago. Despite this, there is still no cure. Sorsha Roberts explains how the AKU Society, a patient... Read more

Supercomputing is the future of pharmacology

25th March 2015

Supercomputing is the future of pharmacologyRick Hillum

According to the US FDA, it currently takes about 12 years and £1.1 billion to get a drug from initial idea to market. Supercomputing technology is reducing this time and... Read more

eyeforpharma Barcelona 2015 (Live feed)

24th March 2015

eyeforpharma Barcelona 2015 (Live feed)

From the 24-26 March pharmaphorum is on-site at eyeforpharma Barcelona, providing live coverage of the event as it takes place. Brought to you in conjunction with IMS Health, the stream... Read more

eyeforpharma Barcelona 2015 hub

24th March 2015

eyeforpharma Barcelona 2015 hub

A key event in the European pharma calendar, eyeforpharma Barcelona provides the latest insight across multiple topics, including salesforce excellence, multichannel marketing, key account management and patient engagement. pharmaphorum is... Read more

News

Pharma supports UK genomics effort

26th March 2015

Pharma supports UK genomics effortStaff reporter

Several pharmaceutical companies have formed a coalition to help the UK government bring its 100,000 Genomes Project to fruition.Ten companies – including UK-based pharma majors AstraZeneca (AZ) and GlaxoSmithKline –... Read more

BMS takes on Novo Nordisk's autoimmune projects

25th March 2015

BMS takes on Novo Nordisk's autoimmune projectsStaff reporter

Bristol-Myers Squibb (BMS) has boosted its position in immunology research by licensing a portfolio of autoimmune disease therapies from Denmark's Novo Nordisk.The Danish drugmaker indicated last year that it intended... Read more

Keytruda beats Yervoy in first-line melanoma

25th March 2015

Keytruda beats Yervoy in first-line melanomaAndrew McConaghie

Merck's cancer immunotherapy drug Keytruda has shown it can extend overall survival and progression free survival in advanced melanoma patients compared to Bristol-Myers Squibb's (BMS) Yervoy.The news is significant, as... Read more

NICE says no to Celgene myeloma drug Imnovid

25th March 2015

NICE says no to Celgene myeloma drug ImnovidAndrew McConaghie

NICE has issued final guidance not recommending Celgene's multiple myeloma treatment Imnovid (pomalidomide).Imnovid was approved in August 2013 for treating patients with multiple myeloma in combination with dexamethasone after two... Read more

Audio & Video

On demand webinar: Staring into the aby…

IMS webinar image 300x200

 

Regardless of the colour of the next UK government that emerges as a result of the May election, the £30–50bn NHS budget chasm... View more

Live Tweetchat: Managing COPD in the rea…

Tweetchat-600x400a

Working in partnership, Atlantis Healthcare and pharmaphorum present a Tweetchat focussed on the real world challenges patients face in managing their COPD,... View more

Live webinar/debate - Feb 4th - COPD, co…

Join the COPD webinar/debate

 

 

COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised... View more

On demand webinar: The Price is Right? -…

Slide-300x200b

 

With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the... View more

White Papers

Optimising patient outcomes through phys…

Optimising patient outcomes through physician educationAnita Seaford

Physician education is undergoing a massive change as the volume of advances in therapies and practices increases and the use of digital channels facilitates new forms of scientific exchange. This white... View info

Is pharma brand marketing dead?

Is pharma brand marketing dead?Mark Sales, Fabrice Bourg & Richard Goosey

This comprehensive supplement brings together a series of articles, insights and discussions produced by Kantar Health in order to help stimulate debate and fresh thinking about the future of pharmaceutical... View info

Improved health and wellbeing in COPD

Improved health and wellbeing in COPDAna Maria Arboleda, Clare Maloney & Prof John Weinman

Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating disorder, which, as it progresses, places a significant burden on individuals and those caring for them. This is not only... View info

Computer Gaming: The Future of Decision-…

Computer Gaming: The Future of Decision-Making for Life Sciences?

How can life science brands identify winning strategic decisions when there are so many variables to consider? One route is via 'road-testing' decisions ahead of sign-off under computer game simulated... View info

Further News & Articles

eyeforpharma Barcelona 2015 day two summary

eyeforpharma Barcelona 2015 day two summary - Wednesday 25th March 2015


18.20 CET
Read more

Articles

eyeforpharma Barcelona 2015 day one summary

eyeforpharma Barcelona 2015 day one summary - Tuesday 24th March 2015

 

18.19 C... Read more

Articles

Can Europe achieve sustainable healthcare? AbbVie wants to help

Pharmaceutical company AbbVie is trying to kick-start a move towards more 'sustainable healthcare' in Europe ... Read more

News

UK cancer survival rates still lagging behind Europe

Cancer survival rates in the UK are still lagging far behind those of other European countries, despite concerte... Read more

News

Novo Nordisk's obesity drug cleared in Europe

The EMA has given a green light to Novo Nordisk's obesity drug Saxenda, adding to earlier approvals in the US an... Read more

News